Growth Metrics

Keros Therapeutics (KROS) Amortizatization of Intangibles (2019 - 2025)

Keros Therapeutics filings provide 7 years of Amortizatization of Intangibles readings, the most recent being $622000.0 for Q4 2025.

  • On a quarterly basis, Amortizatization of Intangibles rose 8.74% to $622000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $2.4 million, a 32.42% increase, with the full-year FY2025 number at $2.4 million, up 32.42% from a year prior.
  • Amortizatization of Intangibles hit $622000.0 in Q4 2025 for Keros Therapeutics, up from $609000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $622000.0 in Q4 2025 to a low of $99000.0 in Q1 2021.
  • Median Amortizatization of Intangibles over the past 5 years was $340000.0 (2023), compared with a mean of $362150.0.
  • Biggest five-year swings in Amortizatization of Intangibles: skyrocketed 157.14% in 2023 and later crashed 35.06% in 2024.
  • Keros Therapeutics' Amortizatization of Intangibles stood at $198000.0 in 2021, then skyrocketed by 62.12% to $321000.0 in 2022, then increased by 4.36% to $335000.0 in 2023, then surged by 70.75% to $572000.0 in 2024, then rose by 8.74% to $622000.0 in 2025.
  • The last three reported values for Amortizatization of Intangibles were $622000.0 (Q4 2025), $609000.0 (Q3 2025), and $595000.0 (Q2 2025) per Business Quant data.